Fentiazac in osteoarthritis: comparison of BID and QID regimens.
This study compares two regimens (twice-a-day and four-times-a-day) of fentiazac for osteoarthritis. The total daily dose for both groups was 400 mg, and the drugs were administered for two months with follow-up evaluations after one, four, and eight weeks of treatment. Thirty patients were studied to evaluate the effect on pain, the functional importance, and the tolerability of fentiazac. Both dosage regimens were equally efficacious, and no advantage except convenience was found for one dosage schedule over the other.